EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Spatial transcriptomics in cancer research and potential clinical impact: a narrative review

Michael A Cilento, Christopher J Sweeney, Lisa M Butler

Journal of Cancer Research and Clinical Oncology · 08.06.2024 · 150 (6)

DOI: 10.1007/s00432-024-05816-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 08.06.2024. Verfasst von Michael A Cilento und 2 weiteren Autor:innen. Beteiligte Einrichtung: South Australian Immunogenomics Cancer Institute, The University of Adelaide, Adelaide, SA, Australia. michael.cilento@adelaide.edu.au. Hauptthemen laut MEDLINE: Neoplasms, Tumor Microenvironment, Transcriptome. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Adelaide.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spatial transcriptomics (ST) provides novel insights into the tumor microenvironment (TME). ST allows the quantification and illustration of gene expression profiles in the spatial context of tissues, including both the cancer cells and the microenvironment in which they are found. In cancer research, ST has already provided novel insights into cancer metastasis, prognosis, and immunotherapy responsiveness. The clinical precision oncology application of next-generation sequencing (NGS) and RNA profiling of tumors relies on bulk methods that lack spatial context. The ability to preserve spatial information is now possible, as it allows us to capture tumor heterogeneity and multifocality. In this narrative review, we summarize precision oncology, discuss tumor sequencing in the clinic, and review the available ST research methods, including seqFISH, MERFISH (Vizgen), CosMx SMI (NanoString), Xenium (10x), Visium (10x), Stereo-seq (STOmics), and GeoMx DSP (NanoString). We then review the current ST literature with a focus on solid tumors organized by tumor type. Finally, we conclude by addressing an important question: how will spatial transcriptomics ultimately help patients with cancer?

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsTumor MicroenvironmentTranscriptomeHumansGene Expression ProfilingPrecision MedicineHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

GeneticsPrecision oncologySolid tumorsSpatial transcriptomicsTumor microenvironment

Autor:innen und Institutionen

  • South Australian Immunogenomics Cancer Institute, The University of Adelaide, Adelaide, SA, Australia. michael.cilento@adelaide.edu.au.
  • South Australian Health and Medical Research Institute, Adelaide, SA, Australia. michael.cilento@adelaide.edu.au.
  • The Queen Elizabeth Hospital, Woodville South, SA, Australia. michael.cilento@adelaide.edu.au.
  • South Australian Immunogenomics Cancer Institute, The University of Adelaide, Adelaide, SA, Australia.
  • South Australian Health and Medical Research Institute, Adelaide, SA, Australia.

Förderung

  • The University of Adelaide

Zitieren

APA

Cilento, M. A., Sweeney, C. J., & Butler, L. M. (2024). Spatial transcriptomics in cancer research and potential clinical impact: a narrative review. Journal of Cancer Research and Clinical Oncology, 150(6). https://doi.org/10.1007/s00432-024-05816-0

Vancouver

Cilento MA, Sweeney CJ, Butler LM. Spatial transcriptomics in cancer research and potential clinical impact: a narrative review. Journal of Cancer Research and Clinical Oncology. 2024;150(6). doi:10.1007/s00432-024-05816-0

BibTeX
@article{Cilento2024,
  author = {Cilento, Michael A and Sweeney, Christopher J and Butler, Lisa M},
  title = {Spatial transcriptomics in cancer research and potential clinical impact: a narrative review},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  volume = {150},
  number = {6},
  doi = {10.1007/s00432-024-05816-0}
}
Kostenlos starten →